CARsgen Therapeutics completes enrollment in Phase II trial of Satri-cel for advanced gastric cancer
CARsgen Therapeutics Holdings Limited, a prominent player in the field of CAR T-cell therapies, has announced the successful completion of patient enrollment for its pivotal ... Read More
FDA sets bold new sodium reduction targets—what this means for your food and health!
In a pivotal move to enhance public health, the U.S. Food and Drug Administration (FDA) has released draft guidance for Phase II of its voluntary ... Read More